Artificial intelligence can do more than assist in the interpretation of patient images. At RSNA 2018, Imalogix showed ...
Volpara Solutions Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for new technologies used in the Volpara Density clinical application for breast density assessment. The updated version of VolparaDensity more accurately reflects breast density from images captured using the Hologic SmartCurve system.
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life. The study is published in the January issue of International Journal of Radiation Oncology • Biology • Physics (Red Journal).
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Konica Minolta Healthcare Americas Inc. released a new software upgrade for the Sonimage HS1 Ultrasound System that delivers workflow improvements, new imaging capabilities and artificial intelligence-assisted functionality for hands-free operation during interventional procedures. Designed with the musculoskeletal (MSK) practitioner in mind, the HS1 System features advanced functionality to support confident diagnoses and treatment management at the point of care.
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc. to improve ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
January 30, 2019 – The Radiological Society of North America (RSNA) published the first issue of its new online journal ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
January 30, 2019 — Magnetic resonance imaging (MRI) provides a safe, noninvasive way to monitor liver fat levels in ...
January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission ...
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell imaging agent. The trial will enroll metastatic cancer patients and will study the correlation of imaging signals observed using ImaginAb’s CD8+ T cell ImmunoPET imaging agent, standard-of-care scans and immunohistochemistry analysis of CD8 in biopsied tissues.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
The odds are good that radiologists want to believe in artificial intelligence (AI). The hype from vendors, professional ...
The importance of early detection of breast cancer has been underscored in recent years as the breast health community ...
January 30, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic ...
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
Artificial intelligence (AI) has been the hot topic discussed at all trade shows, and the 2018 American Society for ...
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodily ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D ...
EBM Technologies announced that its vendor-neutral, remote reading system Rad@ has been granted Class II U.S. Food and Drug Administration (FDA) clearance for diagnostic reading of radiological images. The system can benefit radiologists by untethering them from traditional fixed workstations and paving the way for greater work flexibility and financial efficiencies. With Rad@, radiologists can now interpret images and make diagnosis independent of their location.
MaxQ AI and GE Healthcare announced that MaxQ's Accipio artificial intelligence (AI) platform will now be a part of GE Healthcare's Computed Tomography (CT) Smart Subscription offering. GE Healthcare's Smart Subscription provides customers with continuous access to the latest imaging software updates, through an available automatic download to their CT scanners from the cloud. As a Smart Subscription offering, hospitals with GE Healthcare CTs can easily and seamlessly integrate MaxQ's Accipio platform, from which Accipio Ix intracranial hemorrhage (ICH) detection software is now available.
X-rays were the first medical imaging technology to be invented, and they remain one of the most commonly performed ...
Artificial intelligence (AI) sizzled at the Radiological Society of North America’s (RSNA) 2018 meeting as vendors ...